T 0451/99 (Synthetic antigens/GENETIC SYSTEMS) vom 14.03.2003
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2003:T045199.20030314
- Datum der Entscheidung
- 14. März 2003
- Aktenzeichen
- T 0451/99
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 86902998.3
- IPC-Klasse
- C12Q 1/70
- Verfahrenssprache
- Englisch
- Verteilung
- An die Kammervorsitzenden verteilt (C)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Weitere Entscheidungen für diese Akte
- T 0451/99 AIDS-related disease/BIO-RAD LABS. 2005-01-13
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- Synthetic antigens for the detection of AIDS-related disease
- Name des Antragstellers
- GENETIC SYSTEMS CORPORATION
- Name des Einsprechenden
- Dade Behring Marburg GmbH
Roche Diagnostics GmbH - Kammer
- 3.3.04
- Leitsatz
The following questions are referred to the Enlarged Board of Appeal:
Is the introduction into a claim of a disclaimer not supported by the application as filed admissible, and therefore the claim allowable under Article 123(2) EPC, when the purpose of the disclaimer is to meet a lack-of-novelty objection pursuant to Article 54(3) EPC?
If yes, what are the criteria to be applied in assessing the admissibility of the disclaimer?
- Relevante Rechtsnormen
- European Patent Convention Art 112(1) 1973European Patent Convention Art 123(2) 1973European Patent Convention Art 54(3) 1973European Patent Convention Art 84 1973
- Schlagwörter
- Allowability of disclaimers - under Article 123(2) EPC - delimitation against Article 54(3) EPC prior art - criteria to be applied - referral to Enlarged Board of Appeal
- Orientierungssatz
- -
ORDER
For these reasons it is decided that:
The following questions are referred to the Enlarged Board of Appeal:
Is the introduction into a claim of a disclaimer not supported by the application as filed admissible, and therefore the claim allowable under Article 123(2) EPC, when the purpose of the disclaimer is to meet a lack-of-novelty objection pursuant to Article 54(3) EPC?
If yes, what are the criteria to be applied in assessing the admissibility of the disclaimer?